Lymphoma: all 5,623 studies
Page 2 of 57. Open to participants first (823), then studies with results posted, then the rest; newest registration first within each.
- Serum Histone Succinylation as a Novel Prognostic Biomarker in Hematological MalignanciesNot yet recruitingNCT07131449
- Odronextamab in Low Tumor Volume Advanced FLRecruitingNCT07128641Phase 2
- Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell LymphomaRecruitingNCT07126236Phase 2
- NB02(POSELTINIB) Monotherapy in R/R Non-Hodgkin's LymphomaRecruitingNCT07114367Phase 1
- uCD7 CART for Relapsed or Refractory CD7 Positive Hematologic MalignanciesRecruitingNCT07109518Phase 1
- A Phase I Dose Finding Study of MB-CART2219.1RecruitingNCT07108868Phase 1
- A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic MalignanciesNot yet recruitingNCT07107204Phase 1/2
- CD180 CART for Relapsed or Refractory CD180 Positive Hematologic MalignanciesRecruitingNCT07106749Phase 1
- Cardiovascular Risk in Children With Chronic Conditions StudyRecruitingNCT07086989
- TLN-121 in Relapsed or Refractory Non-Hodgkin LymphomasRecruitingNCT07082803Phase 1
- Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)Not yet recruitingNCT07072585Phase 2/3
- Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced SarcomasRecruitingNCT07066982Phase 1/2
- Anbalcabtagene Autoleucel in Relapsed/Refractory CNS LymphomaRecruitingNCT07062627Phase 2
- WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)RecruitingNCT07058064Not applicable
- A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesRecruitingNCT07052916Not applicable
- Mosunetuzumab for CLL MRD ClearanceRecruitingNCT07052695Phase 1/2
- The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyRecruitingNCT07039474
- A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )Not yet recruitingNCT07032324Phase 1
- Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IVRecruitingNCT07032103
- A Multicenter, Single-Arm, Open-Label, Phase II Trial of Mosunetuzumab in Combination With Tislelizumab for r/r FLNot yet recruitingNCT07031700Phase 2
- JWCAR239 in Patients With B Cell Non-Hodgkin LymphomaNot yet recruitingNCT07024147Phase 1
- Orelabrutinib Combined With Rituximab as First-line Systemic Treatment for Marginal Zone LymphomaRecruitingNCT07022223Phase 2
- A Platform Trial Evaluating New Drugs or Combination in R/R Peripheral T-cell LymphomasRecruitingNCT07018752Phase 1/2
- A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaRecruitingNCT07015242Phase 2
- High-Dose Gemcitabine, Busulfan, and Thiotepa Followed by ASCT in Primary Central Nervous System LymphomaRecruitingNCT07014943Phase 2
- Phase II Trial of Maribavir for CMV in Patients With Lymphoid Malignancy on Bispecific AntibodiesRecruitingNCT07014319Phase 2
- Increasing Resiliency Among Early Post-Treatment Lymphoma SurvivorsRecruitingNCT07014293Not applicable
- A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma SurvivorshipRecruitingNCT07013435Not applicable
- CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute LeukemiaNot yet recruitingNCT07008872Not applicable
- BR Combined With OR in Treatment-naïve Marginal Zone LymphomaNot yet recruitingNCT07008053Phase 2
- RGL-305+ Lymphoma + Exploratory Clinical StudyRecruitingNCT07006012Not applicable
- A Study to Evaluate the Safety and Clinical Efficacy of STR-P004Not yet recruitingNCT07003178Early Phase 1
- Selinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II StudyRecruitingNCT07002099Phase 2
- Evaluation of the Efficacy and Safety of Polatuzumab Vedotin Combined With Rituximab, Gemcitabine, and Oxaliplatin (Pola-R-GemOx) as Salvage Therapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients Ineligible for Autologous TransplantationRecruitingNCT07001540Phase 2
- A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell LymphomaRecruitingNCT07000617Phase 2
- Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell LymphomaRecruitingNCT06996132Phase 2
- Efficacy and Safety Evaluation of U01(ssCART-19) in B-Cell LymphomaRecruitingNCT06987916Phase 1/2
- CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms and Lymphomas/Leukemias With Plasmacytic DifferentiationNot yet recruitingNCT06986434Early Phase 1
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström MacroglobulinemiaRecruitingNCT06986174Phase 2
- A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient MalignaciesRecruitingNCT06971523Phase 1/2
- Chimeric Antigen Receptor Natural Killer Cell Therapy for High-risk Lymphoma Patients With Primary Sjogren's SyndromeRecruitingNCT06967038Phase 1/2
- A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCLRecruitingNCT06966154Phase 1/2
- A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell LymphomaNot yet recruitingNCT06963632
- Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell LymphomaRecruitingNCT06961669Not applicable
- Obinutuzumab With CHOP Versus Obinutuzumab With Bendamustine in the Treatment of Newly Diagnosed Follicular Lymphoma Grade 3ANot yet recruitingNCT06961500Phase 2
- Mosaic Trial for Stem Cell Transplant RecipientsRecruitingNCT06960993Not applicable
- Zanubrutinib Combined With G-CVP in Previously Untreated FLRecruitingNCT06959732Phase 2
- Glofitamab for Consolidation After First-line Treatment of High-risk Large B-cell LymphomaNot yet recruitingNCT06956092Phase 4
- Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)RecruitingNCT06954805Phase 2
- A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.Not yet recruitingNCT06953739Phase 3
- Rituximab, Methotrexate, and Tepadina Induction Followed by Etoposide and Cytarabine Consolidation in Primary Central Nervous System LymphomaRecruitingNCT06946407Not applicable
- JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ LeukemiaRecruitingNCT06940960Not applicable
- Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell LymphomaNot yet recruitingNCT06935136Not applicable
- Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or LymphomaRecruitingNCT06934382Phase 1
- Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab TreatmentEnrolling by invitationNCT06931613Phase 2
- CD7 CAR T-Cell Therapy for r/r T-cell LymphomasRecruitingNCT06925464Phase 1/2
- Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND TrialRecruitingNCT06923397Not applicable
- Progressive Muscle Relaxation Exercises on Sleep, Fatigue, Pain in Lymphoma PatientsEnrolling by invitationNCT06920095Not applicable
- Phase II Trial of BrECADD in HIV-Positive Patients With Advanced-Stage Classical Hodgkin LymphomaNot yet recruitingNCT06919679Phase 2
- Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy FailureRecruitingNCT06918912Phase 2
- Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular LymphomaNot yet recruitingNCT06918015Phase 2
- Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic LymphomaRecruitingNCT06916767Phase 1
- Phase II Trial of Anti-PD-1 Antibody Treatment and Radiotherapy in Early-stage Favorable Classic Hodgkin LymphomaNot yet recruitingNCT06916416Phase 2
- A Study of Carmustine With and Without Ethanol in Subjects With LymphomaRecruitingNCT06915246Phase 2
- A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological MalignanciesRecruitingNCT06914037Phase 1
- The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic TumorsRecruitingNCT06911710Phase 1/2
- Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell LymphomaRecruitingNCT06902012Phase 1/2
- Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic MalignancyRecruitingNCT06895538Phase 2/3
- Chidamide Plus R-CHOP in Newly Diagnosed Double-Expressor Diffuse Large B-Cell Lymphoma With Other Molecular SubtypesRecruitingNCT06891157Phase 2
- Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCLNot yet recruitingNCT06890585Phase 2
- Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's LymphomaNot yet recruitingNCT06890091
- JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ LeukemiaRecruitingNCT06890065Not applicable
- Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-HodgkinRecruitingNCT06883604Not applicable
- Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory LymphomaRecruitingNCT06883526Phase 1/2
- JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell LymphomaNot yet recruitingNCT06879470Not applicable
- Relma-cel Followed by Tislelizumab for the Treatment of Relapsed/Refractory CNS Large B-Cell LymphomaRecruitingNCT06876688Phase 2
- GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHLRecruitingNCT06875063Phase 1
- Nivolumab and DA-EPOCH-R in Pediatric Primary Mediastinal (Thymic) Large B-cell LymphomaEnrolling by invitationNCT06871007Phase 1/2
- Hypofractionation Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse B-cell Lymphoma With Baseline High Tumor BurdenRecruitingNCT06867536Phase 2
- CD-19 CAR-T Cell for Pediatric ALL or LymphomaRecruitingNCT06866873Not applicable
- The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell LymphomaNot yet recruitingNCT06863441
- Combating Cancer-Related Fatigue: A Personalized Supportive Care ProgramRecruitingNCT06860880Not applicable
- A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationRecruitingNCT06859424Phase 2
- Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantRecruitingNCT06856226
- A Phase I/II Study of Golidocitinib Combined with Pomalidomide in R/R PTCLRecruitingNCT06855823Phase 1/2
- Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell LymphomaRecruitingNCT06854445Phase 2
- BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell LymphomaRecruitingNCT06854003Phase 2
- CD70-targeted immunoPET Imaging of Malignant CancersRecruitingNCT06852638Phase 2
- CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory LymphomaRecruitingNCT06850285Not applicable
- Improving Genomic Profiling and Reducing Time to Cancer Treatment Via Targeted Use of Endoscopic UltrasoundEnrolling by invitationNCT06848738Not applicable
- Sintilimab Plus AVD in Pediatric Low/Moderate Risk Hodgkin Lymphoma: a Phase II StudyRecruitingNCT06848569Phase 2
- Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell LymphomaRecruitingNCT06846489Phase 2
- Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients with Relapsed or Refractory Non-Hodgkin LymphomaNot yet recruitingNCT06845241Phase 1/2
- CAR2219 CAR-T Cells for the Treatment of R/R B Cell Leukemia and LymphomaRecruitingNCT06834529Phase 1/2
- Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCLRecruitingNCT06832267Not applicable
- Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCLRecruitingNCT06832228Not applicable
- A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in IndiaRecruitingNCT06831370Phase 4
- Adjusted High-dose Chemotherapy with Autologous Stem Cell Transplant Vs. Conventional Immunochemotherapy in Elderly PCNSL PatientsRecruitingNCT06830421Phase 3
- Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular LymphomaRecruitingNCT06826118Phase 2
- Sintilimab, Pegaspargase Plus GemOx for Untreated Extranodal NK/T-Cell LymphomaRecruitingNCT06824883Phase 2